Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States
Author(s) -
Bobby Daly,
Olufunmilayo I. Olopade,
Ningqi Hou,
Katharine Yao,
David J. Winchester,
Dezheng Huo
Publication year - 2017
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2016.6380
Subject(s) - medicine , breast cancer , cancer , cancer registry , concordance , cohort , proportional hazards model , retrospective cohort study , cohort study , adjuvant therapy , oncology , gynecology
Randomized trials in breast cancer have demonstrated the clinical benefits of adjuvant endocrine therapy (AET) in preventing recurrence and death. The examination of concordance with AET guidelines at a national level as a measure of quality of care is important.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom